GALNT5 and prostate carcinoma: The tumor aggressiveness of prostate cancer cell lines has been linked to the expression of GALNT5 and ST3GAL6, mediating the synthesis of α2–3 sialic acids and especially sialyl-LewisA on MUCs in prostate cancer cell lines (42, 43).